TruPlan vs Discovery MI Gen2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
TruPlan is a specialized software for pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures, leveraging AI for detailed anatomical assessment and simulation from CT images. In contrast, Discovery MI Gen2 is a physical PET/CT imaging system that utilizes deep-learning AI to enhance image acquisition, reconstruction, and motion correction for general diagnostic purposes across oncology, neurology, and cardiology. While both involve AI in medical imaging for cardiology, TruPlan focuses on specific procedural analysis, whereas Discovery MI Gen2 is an imaging modality for data generation.
Choose TruPlan if…
Choose TruPlan if your primary need is highly specialized, AI-driven pre-procedural planning and post-procedural follow-up specifically for Left Atrial Appendage Closure (LAAC) procedures. This tool excels in providing detailed 3D anatomical assessment, automated LAA landing zone definition, and realistic TEE, ICE, and fluoroscopic simulations to optimize device selection and placement.
View TruPlan →Choose Discovery MI Gen2 if…
Choose Discovery MI Gen2 if your institution requires a state-of-the-art digital PET/CT system for comprehensive diagnostic imaging across oncology, neurology, and cardiology. This system is ideal for scenarios demanding superior image quality, high sensitivity, and accurate quantitation, especially when aiming to improve small lesion detectability and reduce scan times and radiation dose through deep-learning AI and advanced motion correction.
View Discovery MI Gen2 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | TruPlan | Discovery MI Gen2 |
|---|---|---|
| Pricing | Unknown | Starts at $15,500.00 |
| Deployment | Standalone software on desktop/laptop or server within hospital infrastructure with thick-client software on multiple desktops/laptops. It runs locally without an internet connection, though license key activation requires a direct internet connection. | On-premise |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | TruPlan | Discovery MI Gen2 |
|---|---|---|
| Product Name | TruPlan | Discovery MI Gen2 |
| Company | Circle Cardiovascular Imaging | GE HealthCare |
| Description | AI-enabled CT imaging software for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures, offering advanced visualization and measurement tools. | Next-generation digital PET/CT system that leverages deep-learning AI, high sensitivity, and advanced motion correction to deliver superior diagnostic imaging for oncology, neurology, and cardiology. |
| Primary Use Case | Left Atrial Appendage Closure (LAAC) pre-procedural planning and post-procedural follow-up | Diagnostic imaging for oncology, neurology, and cardiology |
| Key Features | AI-enabled Left Heart Segmentation, Automated LAA Landing Zone Definition, 3D Anatomical Assessment (segmentation, sculpting), TEE Simulation (0-45-90-135, bicaval, Ao short axis views), ICE Simulation, Fluoroscopic Rendering Simulation, Measurement and Annotation Tools, Thrombus Assessment Tool | LightBurst Digital Detector with scalable axial FOV up to 30 cm, High sensitivity (up to 125% increase, 30 cps/kBq), TrueFidelityu2122 deep-learning based image reconstruction, Q.Clear quantitation for accurate SUV measurements and noise reduction, MotionFree digital respiratory motion management solution, Automated patient positioning system (Auto IN), Reduced scan times (up to 50% reduction) and injected dose (up to 50% reduction), Improved small lesion detectability (up to 41% increase) |
Videos
Demos, reviews, and walkthroughs featuring TruPlan and Discovery MI Gen2.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
TruPlan is an AI-enabled CT imaging software specifically for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures, serving Cardiology, Cardiothoracic Surgery, and Radiology. Discovery MI Gen2 is a next-generation digital PET/CT system designed for superior diagnostic imaging across oncology, neurology, and cardiology, primarily benefiting Nuclear Medicine, Oncology, and Radiology specialties.
TruPlan's AI is focused on specific LAAC procedural tasks, including AI-enabled left heart segmentation, automated LAA landing zone definition, and 3D anatomical assessment. In contrast, Discovery MI Gen2 leverages deep-learning AI for image reconstruction (TrueFidelityu2122), advanced motion correction (MotionFree), and improved small lesion detectability in its broader diagnostic imaging applications.
TruPlan is exclusively resold by Boston Scientific for WATCHMAN procedures and may be accessible at no additional cost through their representatives; Circle CVI's broader cvi42 platform offers a flexible subscription model. Discovery MI Gen2 represents a significant capital investment, with refurbished ultra-premium digital PET/CT systems ranging from $950,000 to $1,900,000.
TruPlan enhances procedural efficiency for LAAC by offering advanced visualization, measurement tools, and simulations like TEE and fluoroscopic rendering, which can lead to smoother procedures and fewer attempted devices. Discovery MI Gen2 improves diagnostic accuracy and efficiency through high sensitivity, Q.Clear quantitation for accurate SUV measurements, reduced scan times (up to 50% reduction), and improved small lesion detectability (up to 41% increase).